Phase II Neoadjuvant Trial of Trastuzumab in Combination With Dose-Dense ABI-007 (Abraxane™)
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Pre operativeTrastuzumab|DRUG: ABI-007 (Abraxane)|DRUG: Vinorelbine
Sponsor: Emory University